REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/02/2025
Back to search
Official data from USPTO
NEUREXPERT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
08/03/2025
Trademark type
Word
Nice classes
42
Filing date
06/03/2015
Registration date
08/02/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/16/2023
Last transaction
08/03/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2013-07-00
First use in commerce
2013-07-00
Drawing code
4
Owner type
99
Owner location
Newcastle Upon Tyne, GB
Examiner
PINO, BRIAN
Law office
M50
Current location
TMO LAW OFFICE 114
Holders and representatives
Holders
Neurexpert Ltd.
Neurexpert Ltd.
Representatives
Lisa Dunner Dunner Law Pllc
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological services and research and design relating theretotestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; scientific analysis and research servicestestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; scientific analysis and research services using cell cultures and/or stem cells to define the action of novel therapeutics in the central nervous systemtestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; scientific laboratoryanalysis and research services for electrophysiology and related techniques to define the action of novel therapeutics in the central nervous systemtestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; scientific laboratoryanalysis and research services providing data on biologicalorganic and non-organic chemical potencyefficacy and mechanism of action at a native biological target in the central nervous systemtestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; scientific laboratoryanalysis and research services measuring biologicalorganic and non-organic chemical compound potency against biological targets coupled to their native transduction pathways and expressed with their naturally occurring subunit conformation and accessory proteins in the central nervous systemtestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; scientific laboratoryanalysis and research services providing functional and mechanistic data on neural mechanisms that underlie higher brain functionssuch as cognitionattention and sensory processingtestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; scientific laboratoryanalysis and research services to define the phenotype of transgenic models at the cellular and neuronal network leveltestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; scientific laboratoryanalysis and research services to produce functional and mechanistic data on the physiological processes that may be affected in central nervous system disorderssuch as the mechanisms underlying learningmemoryattention and sensory processingtestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; scientific laboratoryanalysis and research services for the provision of scientific functional and mechanistic data on neurophysiological diseasesincluding psychiatryneurologyneurodegenerationepilepsypainophthalmology and retinal neurodegenerationtestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; scientific laboratoryanalysis and research services for the provision of scientific functional and mechanistic data on biological targetsincluding ligand and voltage gated ion channelsG-protein coupled receptors and biological transporterstestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; scientific laboratory services to discover and research the biological site of action of novel therapeutics within a cellular and neuronal networktestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; design and development of assays using cell cultures and/or stem cellstestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; design and development of electrophysiology and electrophysiological assaystestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; design and development of laboratory equipment assays using cell cultures and/or stem cells and laboratory consumables thereforfor testingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; design and development of laboratory equipment for electrophysiology and electrophysiological assays and laboratory consumables therefortestingscreening and analysis of pharmaceuticals and naturally occurring substanceschemical screening and analysistestingscreening and analysis of biological substancesperforming pharmaceutical screening assays for othersevaluation of mechanisms of action of pharmaceuticals and naturally occurring substancesidentification of changes in biological functions in models of disease; scientific research consulting in the field of assays using and/or including cell cultures and/or stem cells; scientific research consulting in the field of electrophysiology and electrophysiological assays; scientific research consulting in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of educational and research project progression for all stages of the drug discovery process; scientific research consulting in the field of educational and research study plans in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of analysis and interpretation of experimental findings in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of the establishment and setting up of new laboratories; scientific research consulting in the field of the establishment and setting up of new laboratories using and/or including cell cultures and/or stem cells; scientific research consulting in the field of the establishment and setting up of new electrophysiology laboratories; scientific research consulting in the field of the design and development of assays for diseases and biological targets in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of the preparation of data for the pharmaceutical industry; scientific research consulting in the field of the preparation of data for the pharmaceutical industry generated from cell cultures and/or stem cells; scientific research consulting in the field of the preparation of electrophysiological data for the pharmaceutical industry; scientific research consulting in the field of the design and development of assays for drug discovery; scientific research consulting in the field of the design and development of assays using and/or including cell cultures and/or stem cells for drug discovery; scientific research consulting in the field of the design and development of electrophysiology assays for drug discovery; scientific research consulting in the field of assays and tests to aid preclinical and clinical drug discovery programsproject progressionexperimental plans and interpretation of data; scientific research consulting in the field of assays and tests using and/or including cell cultures and/or stem cells to aid preclinical and clinical drug discovery programsproject progressionexperimental plans and interpretation of data; scientific research consulting in the field of electrophysiology and electrophysiological assays and tests to aid preclinical and clinical drug discovery programsproject progressionexperimental plans and interpretation of data; scientific research consulting in the field of equipment purchasedesign and assembly of laboratories for in vitro and in vivo assays and tests; scientific research consulting in the field of equipment purchasedesign and assembly of laboratories using and/or including cell cultures and/or stem cells for in vitro assays and tests; scientific research consulting in the field of equipment purchasedesign and assembly of electrophysiology laboratories for in vitro and in vivo assays and tests; scientific research technology consulting services to the pharmaceutical industry on clinical and preclinical research in the fields of electrophysiologyneurophysiology and neuropharmacology; scientific research consulting services in neuroscience and translational research for disorders including neurologyneurodegenerationpsychiatryepilepsypain and ophthalmology; scientific research technology consulting services providing guidance and experimental support for drug discovery research from target identification and validation through to candidate selection and progression to the clinic; scientific research consulting services on all applications of electrophysiologyincluding safety testingdrug screeningautomated platforms and development of functional biomarkers
Publications
History of USPTO decisions and trademark events.
24 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/16/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/16/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/16/2023
E815
TEAS SECTION 8 & 15 RECEIVED
08/01/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/02/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/02/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/17/2016
PUBO
PUBLISHED FOR OPPOSITION
05/17/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/27/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/13/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/05/2016
DMCC
DATA MODIFICATION COMPLETED
03/12/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/03/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/22/2015
GNRT
NON-FINAL ACTION E-MAILED
09/22/2015
CNRT
NON-FINAL ACTION WRITTEN
09/22/2015
DMCC
DATA MODIFICATION COMPLETED
09/15/2015
ALIE
ASSIGNED TO LIE
09/15/2015
DOCK
ASSIGNED TO EXAMINER
09/15/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/09/2015
NWAP
NEW APPLICATION ENTERED
06/06/2015
Continuous trademark protection
Get notified about every new filing that threatens NEUREXPERT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.